- AI across pathology and genomics knowledge
- Built specifically for pathology teams, not bolt-on AI
- Scales to organization-wide healthcare rollouts
OptraHEALTH
AI for pathology and genomics knowledge
SF6.8
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Bridge pathology labs and biopharmaLabs and genomics focused programs
Bridge pathology labs and biopharmaLabs and genomics focused programs
Best for
Labs and genomics-focused programs
Pricing
Custom
SoftFinders Score
6.8 / 10
Overview
What is OptraHEALTH?
OptraHEALTH is a company applying AI to genomics and pathology workflows including genetic counseling and lab knowledge tools. The product is positioned around digital slide workflow, image analysis, and case prioritization rather than autonomous diagnosis, and pathologist review of every flagged case remains essential for clinical sign-off. Buyers should confirm lab information system integration depth, slide scanner compatibility, and validation evidence for the specific tissue types under review.
For labs and genomics-focused programs, OptraHEALTH is worth a serious look thanks to AI across pathology and genomics knowledge. Just keep one limitation in view: narrower public footprint than larger peers. Pricing is sales-led and scoped per buyer rather than posted publicly. Verify EHR or workflow fit, scope, and support before committing.
KEY FEATURES
What you get out of the box
Lab Integration
Connects with lab information systems
Quality Review
Supports quality control across cases
Research Modules
Modules for translational research workflows
Case Sharing
Shares cases across teams for second review
Slide Management
Manages and routes digitized pathology slides
Image Analysis
AI-assisted analysis of tissue images
USE CASES
Where teams put it to work
Bridge pathology labs and biopharma
Support image analysis for cancer cases
Enable telepathology consult workflows
Manage digital pathology slides centrally
Support biomarker workflows for research
Route cases for specialty review
Editorial Take
What we like, and what to verify
- Narrower public footprint than larger peers
- Pathologist sign-off required on every case
- Pricing is sales-led and needs scoping upfront
Screenshots
A look inside
Alternatives
Tools to consider next
Ibex Medical Analytics SF 7.8
Why consider it
AI cancer detection for biopsy slides
Visiopharm SF 7.5
Why consider it
Quantitative digital pathology image analysis
Indica Labs SF 7.6
Why consider it
HALO digital pathology image analysis platform
Aiforia SF 7.4
Why consider it
Cloud deep learning for tissue analysis
Mindpeak SF 7.2
Why consider it
Consistency-focused AI tumor analysis tools
PreciseDx SF 7
Why consider it
Quantitative AI cancer grading and risk
FAQ